GB201508380D0 - Methods for diagnosis, prognosis, and of determining the treatment for acute leukaemia - Google Patents
Methods for diagnosis, prognosis, and of determining the treatment for acute leukaemiaInfo
- Publication number
- GB201508380D0 GB201508380D0 GBGB1508380.1A GB201508380A GB201508380D0 GB 201508380 D0 GB201508380 D0 GB 201508380D0 GB 201508380 A GB201508380 A GB 201508380A GB 201508380 D0 GB201508380 D0 GB 201508380D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- prognosis
- diagnosis
- determining
- treatment
- methods
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 206010000830 Acute leukaemia Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000004393 prognosis Methods 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
- G01N33/5041—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects involving analysis of members of signalling pathways
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57426—Specifically defined cancers leukemia
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Toxicology (AREA)
- Ecology (AREA)
- Physiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US25413109P | 2009-10-22 | 2009-10-22 | |
US26558509P | 2009-12-01 | 2009-12-01 | |
US26574309P | 2009-12-01 | 2009-12-01 | |
US35086410P | 2010-06-02 | 2010-06-02 | |
US37319910P | 2010-08-12 | 2010-08-12 | |
US37461310P | 2010-08-18 | 2010-08-18 | |
US38279310P | 2010-09-14 | 2010-09-14 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201508380D0 true GB201508380D0 (en) | 2015-07-01 |
Family
ID=43334232
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1017857A Withdrawn GB2474777A (en) | 2009-10-22 | 2010-10-22 | Methods for diagnosis, prognosis, and of determining the treatment for acute leukaemia |
GBGB1508380.1A Ceased GB201508380D0 (en) | 2009-10-22 | 2015-05-15 | Methods for diagnosis, prognosis, and of determining the treatment for acute leukaemia |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB1017857A Withdrawn GB2474777A (en) | 2009-10-22 | 2010-10-22 | Methods for diagnosis, prognosis, and of determining the treatment for acute leukaemia |
Country Status (1)
Country | Link |
---|---|
GB (2) | GB2474777A (en) |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009025847A2 (en) * | 2007-08-21 | 2009-02-26 | Nodality, Inc. | Methods for diagnosis, prognosis and methods of treatment |
US20090291458A1 (en) * | 2008-05-22 | 2009-11-26 | Nodality, Inc. | Method for Determining the Status of an Individual |
EP2304436A1 (en) * | 2008-07-10 | 2011-04-06 | Nodality, Inc. | Methods for diagnosis, prognosis and treatment |
US20100099109A1 (en) * | 2008-10-17 | 2010-04-22 | Nodality, Inc., A Delaware Corporation | Methods for Analyzing Drug Response |
US8242248B2 (en) * | 2009-03-23 | 2012-08-14 | Nodality, Inc. | Kits for multiparametric phospho analysis |
WO2010135608A1 (en) * | 2009-05-20 | 2010-11-25 | Nodality, Inc. | Methods for diagnosis, prognosis and methods of treatment |
-
2010
- 2010-10-22 GB GB1017857A patent/GB2474777A/en not_active Withdrawn
-
2015
- 2015-05-15 GB GBGB1508380.1A patent/GB201508380D0/en not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
GB201017857D0 (en) | 2010-12-01 |
GB2474777A (en) | 2011-04-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2179037A4 (en) | Methods for diagnosis, prognosis and methods of treatment | |
GB0906458D0 (en) | Macromolecules for diagnosis and prognosis | |
EP2323677A4 (en) | Micro-rna-based compositions and methods for the diagnosis, prognosis and treatment of multiple myeloma | |
HK1187377A1 (en) | Method for the diagnosis, prognosis and treatment of breast cancer metastasis | |
EP2257647A4 (en) | MicroRNA-BASED METHODS AND COMPOSITIONS FOR THE DIAGNOSIS, PROGNOSIS AND TREATMENT OF GASTRIC CANCER | |
HK1208501A1 (en) | Method for the diagnosis, prognosis and treatment of lung cancer metastasis | |
HK1199754A1 (en) | Method for monitoring, diagnosis and or prognosis of acute kidney injury in early stage | |
EP2652506A4 (en) | The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer | |
IL212898A0 (en) | Processing blood | |
IL247324A0 (en) | Microrna patterns for the diagnosis, prognosis and treatment of melanoma | |
WO2011008262A9 (en) | Methods and apparatus for diagnosis and/or prognosis of cancer | |
ZA201300519B (en) | Novel antibody for the diagnosis and/or prognosis of cancer | |
AP2011005824A0 (en) | Methods for treating acute myocardial infarctions and associated disorders. | |
PT3029156T (en) | Method for the diagnosis and/or prognosis of acute renal damage | |
EP2393416A4 (en) | Methods and apparatuses for quantitatively determining the likelihood of a disease | |
EP2657706A4 (en) | Biomarker for cognitive dysfunction diseases, and method for detection of cognitive dysfunction diseases using the biomarker | |
EP2652508A4 (en) | The use of anti-cxcl13 and anti-cxcr5 antibodies for the treatment or detection of cancer | |
ZA200808669B (en) | Methods of treating, diagnosing or detecting cancer | |
EP2402744A4 (en) | Carburization detection method | |
HK1184199A1 (en) | Biosensor test member and method for making the same | |
EP2888370A4 (en) | Methods for diagnosis, prognosis and methods of treatment | |
EP2016172A4 (en) | Diagnostic methods for determining treatment | |
EP2493494A4 (en) | Methods and kits for preventing hypoglycemia | |
BRPI0822129A2 (en) | Aldh-2c inhibitors in the treatment of addiction. | |
HK1174955A1 (en) | Detecting pax2 for the diagnosis of breast cancer pax2 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R108 | Alteration of time limits (patents rules 1995) |
Free format text: EXTENSION ALLOWED Effective date: 20160101 Free format text: EXTENSION APPLICATION Effective date: 20150911 |
|
AT | Applications terminated before publication under section 16(1) |